EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Show more...
FAQ
AdvanSource Biomaterials 今天的股价是多少?▼
ASNB 当前价格为 $0.85 USD,过去 24 小时上涨了 +6.58%。在图表上更密切关注 AdvanSource Biomaterials 股价表现。
AdvanSource Biomaterials 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,AdvanSource Biomaterials 的股票以代码 ASNB 进行交易。
AdvanSource Biomaterials 的市值是多少?▼
今天 AdvanSource Biomaterials 的市值为 4.83M
AdvanSource Biomaterials 上一季度的财报怎么样?▼
ASNB 上季度财报为每股 -0.01 USD,预估为 不适用 USD,带来 不适用 的意外。下季度预估财报为每股 不适用 USD。
AdvanSource Biomaterials 去年的营收是多少?▼
AdvanSource Biomaterials 去年的营收为 0USD。
AdvanSource Biomaterials 去年的净利润是多少?▼
ASNB 去年的净收益为 -5.99MUSD。
AdvanSource Biomaterials 会发放股息吗?▼
是的,ASNB 的股息每 zh 发放一次。每股最新股息为 0.18 USD。截至今日,股息率(FWD)% 为 0%。
AdvanSource Biomaterials 有多少名员工?▼
截至四月 01, 2026,公司共有11名员工。
AdvanSource Biomaterials 属于哪个行业?▼
AdvanSource Biomaterials从事于Manufacturing行业。
AdvanSource Biomaterials 何时完成拆股?▼
AdvanSource Biomaterials 最近没有进行任何拆股。